Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
120Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $71.61M | $-48.59M | $-1.74 |
| 2024 | $64.25M | $-61.84M | $-2.39 |
| 2023 | $50.14M | $-35.38M | $-1.40 |
| 2022 | $34.42M | $-26.66M | $-1.07 |
| 2021 | $33.02M | $-25.14M | $-1.03 |
Social Signal Score
Earnings
Thu, Nov 5(in 3 months)
Consensus estimate $-0.27 per share
Typical surprise -7.0% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Aug 6$-0.25 vs $-0.29beat
- Thu, May 14$-0.35 vs $-0.35beat
- Thu, Feb 12$-0.38 vs $-0.36miss
- Thu, Nov 6$-0.46 vs $-0.43miss
- Thu, Aug 7$-0.38 vs $-0.26miss
- Thu, May 8$-0.53 vs $-0.39miss
Estimates and results for RCEL via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
RCELhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Mentions (2)
- Newsseekingalpha.com·2d ago·Positive
AVITA Medical, Inc. (RCEL) Shareholder/Analyst Call Transcript AVITA Medical, Inc. (RCEL) Shareholder/Analyst Call Transcript
View source ↗ - Newsglobenewswire.com·5d ago·Neutral
AVITA Medical to Host Investor Webinar Briefing VALENCIA, Calif., Aug. 09, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, invites shareholders and prospective investors to attend its investor webinar briefing and presentation by Cary Vance, President and Chief Executive Officer, and David O'Toole, Chief Financial Officer, on August 12, 2026, at 4:00 p.m.
View source ↗
